UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050389
Receipt number R000057375
Scientific Title Preimplantation genetic testing for monogenic disease (neonatal infammatory skin and bowel disease 1)
Date of disclosure of the study information 2023/03/27
Last modified on 2023/02/20 17:00:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preimplantation genetic testing for monogenic disease (neonatal infammatory skin and bowel disease 1)

Acronym

Preimplantation genetic testing for monogenic disease (neonatal infammatory skin and bowel disease 1)

Scientific Title

Preimplantation genetic testing for monogenic disease (neonatal infammatory skin and bowel disease 1)

Scientific Title:Acronym

Preimplantation genetic testing for monogenic disease (neonatal infammatory skin and bowel disease 1)

Region

Japan


Condition

Condition

neonatal infammatory skin and bowel disease 1

Classification by specialty

Gastroenterology Pediatrics Dermatology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Not to deliver affected fetus

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

delivery of a baby without neonatal infammatory skin and bowel disease 1

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

trophectoderm biopsy, DNA extraction, whole genome amplification and genetic testing for ADAM17 gene

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

compound heterozygous of ADAM17 missense

Key exclusion criteria

none

Target sample size

1


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Iwasa

Organization

tokushima university hospital

Division name

Obstetrics and Gynecology

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima

TEL

+81-88-633-7177

Email

yamamoto.yuri@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Yuri
Middle name
Last name Yamamoto

Organization

tokushima university hospital

Division name

Obstetrics and Gynecology

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima

TEL

+81886337177

Homepage URL


Email

yamamoto.yuri@tokushima-u.ac.jp


Sponsor or person

Institute

tokushima university hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

tokushima university hospital

Address

3-18-15 Kuramoto-cho, Tokushima

Tel

+81886337177

Email

yamamoto.yuri@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 10 Month 01 Day

Date of IRB

2023 Year 03 Month 27 Day

Anticipated trial start date

2023 Year 04 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 02 Month 20 Day

Last modified on

2023 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057375


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name